Page last updated: 2024-09-04

glucagon and 4-iodo-2,5-dimethoxyphenylisopropylamine

glucagon has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(4-iodo-2,5-dimethoxyphenylisopropylamine)
Trials
(4-iodo-2,5-dimethoxyphenylisopropylamine)
Recent Studies (post-2010) (4-iodo-2,5-dimethoxyphenylisopropylamine)
26,0391,4983,0548431127

Protein Interaction Comparison

ProteinTaxonomyglucagon (IC50)4-iodo-2,5-dimethoxyphenylisopropylamine (IC50)
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0032

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugimoto, Y; Yamada, J1

Other Studies

1 other study(ies) available for glucagon and 4-iodo-2,5-dimethoxyphenylisopropylamine

ArticleYear
Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:12

    Topics: Adrenal Medulla; Amphetamines; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucagon; Hyperglycemia; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists

2000